Involvement of reactive oxygen species and SP-1 in fibronectin production by oxidized LDL

Biochemical and Biophysical Research Communications

Volumn 310, Issue 2, 2003, Pages 491-497

  Akiba, Satoshi ^a   Chiba, Masahiro ^a   Mukaida, Yuki ^a   Sato, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Extracellular matrix protein; Fibronectin; Mesangial cell; Oxidized LDL; Reactive oxygen species

Indexed keywords

7 OXOCHOLESTEROL; ACETYLCYSTEINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITHRAMYCIN; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LIPID OXIDATION; LIPID STORAGE; LIPOGENESIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0141793770     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.042     Document Type: Article

References (43)

1. Keane W.F., Kasiske B.L., O'Donnell M.P. Lipids and progressive glomerulosclerosis: a model analogous to atherosclerosis. Am. J. Nephrol. 8:1988;261-271.
2. Diamond J.R. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int. 39(Suppl. 31):1991;S29-S34.
3. Wanner C., Greiber S., Krämer-Guth A., Heinloth A., Galle J. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a). Kidney Int. 52(Suppl. 63):1997;S102-S106.
4. Kamanna V.S. Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease. Histol. Histopathol. 17:2002;497-505.
5. Rovin B.H., Tan L.C. LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int. 43:1993;218-225.
6. Lee H.S., Kim B.C., Hong H.K., Kim Y.S. LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGFβ expression. Am. J. Physiol. 277:1999;F369-F376.
7. Nishida Y., Yorioka N., Oda H., Yamakido M. Effect of lipoproteins on cultured human mesangial cells. Am. J. Kidney Dis. 29:1997;919-930.
8. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:1984;3883-3887.
9. Zhu H., Takahashi Y., Xu W., Kawajiri H., Murakami T., Yamamoto M., Iseki S., Iwasaki T., Hattori H., Yoshimoto T. Low density lipoprotein receptor-related protein-mediated membrane translocation of 12/15-lipoxygenase is required for oxidation of low density lipoprotein by macrophages. J. Biol. Chem. 278:2003;13350-13355.
10. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
11. Lusis A.J. Atheroscler. Nat. 407:2000;233-241.
12. Wheeler D.C., Chana R.S., Topley N., Petersen M.M., Davies M., Williams J.D. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int. 45:1994;1628-1636.
13. Magil A.B., Frohlich J.J., Innis S.M., Steinbrecher U.P. Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int. 43:1993;1243-1250.
14. Lee H.S., Kim Y.S. Identification of oxidized low density lipoprotein in human renal biopsies. Kidney Int. 54:1998;848-856.
15. Matoba K., Ozaki M., Yamada Y., Mune M., Yukawa S. Oxidized low density lipoproteins stimulate eicosanoid synthesis in mesangial cells. Clin. Exp. Nephrol. 1:1997;20-27.
16. 2 activity in ox-LDL-stimulated mesangial cells and modulation by α-tocopherol. Kidney Int. 56(Suppl. 71):1999;S171-S173.
17. Kamanna V.S., Pai R., Ha H., Kirschenbaum M.A., Roh D.D. Oxidized low-density lipoprotein stimulates monocyte adhesion to glomerular endothelial cells. Kidney Int. 55:1999;2192-2202.
18. Chana R.S., Wheeler D.C. Fibronectin augments monocyte adhesion to low-density lipoprotein-stimulated mesangial cells. Kidney Int. 55:1999;179-188.
19. Kamanna V.S., Pai R., Roh D.D., Kirschenbaum M.A. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation. Lab. Invest. 74:1996;1067-1079.
20. Sharma P., Reddy K., Franki N., Sanwal V., Sankaran R., Ahuja T.S., Gibbons N., Mattana J., Singhal P.C. Native and oxidized low density lipoproteins modulate mesangial cell apoptosis. Kidney Int. 50:1996;1604-1611.
21. Roh D.D., Kamanna V.S., Kirschenbaum M.A. Oxidative modification of low-density lipoprotein enhances mesangial cell protein synthesis and gene expression of extracellular matrix proteins. Am. J. Nephrol. 18:1998;344-350.
22. Chen H.-C., Guh J.-Y., Shin S.-J., Lai Y.-H. Pravastatin suppress superoxide and fibronectin production of glomerular mesangial cells induced by oxidized-LDL and high glucose. Atherosclerosis. 160:2002;141-146.
23. Shah S.V. The role of reactive oxygen metabolites in glomerular disease. Annu. Rev. Physiol. 57:1995;245-262.
24. Kashihara N., Sugiyama H., Makino H. Mechanisms for induction of apoptosis and glomerular disease. Nephrol. Dial. Transplant. 14(Suppl. 1):1999;52-54.
25. Mason R.M., Wahab N.A. Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 14:2003;1358-1373.
26. 2 and PDGF in mesangial cells. Am. J. Physiol. 282:2002;F485-F491.
27. 2 to supply fatty acids required for cholesterol esterification. J. Lipid Res. 44:2003;1676-1685.
28. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:1976;212-216.
29. Hayama M., Inoue R., Akiba S., Sato T. Inhibitory effect of cepharanthine on fibronectin production in growth factor-stimulated rat mesangial cells. Eur. J. Pharmacol. 390:2000;37-42.
30. Lee B.-H., Park S.-Y., Kang K.-B., Park R.-W., Kim I.-S. NF-κB activates fibronectin gene expression in rat hepatocytes. Biochem. Biophys. Res. Commun. 279:2002;1218-1224.
31. Chen S., Mukherjee S., Chakraborty C., Chakrabarti S. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-κB and AP-1. Am. J. Physiol. 284:2003;C263-C272.
32. Dean D.C., McQuillan J.J., Weintraub S. Serum stimulation of fibronectin gene expression appears to result from rapid serum-induced binding of nuclear proteins to a cAMP response element. J. Biol. Chem. 265:1990;3522-3527.
33. Reddy M.A., Adler S.G., Kim Y.-S., Lanting L., Rossi J., Kang S.-W., Nadler J.L., Shahed A., Natarajan R. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am. J. Physiol. 283:2002;F985-F994.
34. Dean D.C., Bowlus C.L., Bourgeois S. Cloning and analysis of the promoter region of the human fibronectin gene. Proc. Natl. Acad. Sci. USA. 84:1987;1876-1880.
35. Suzuki M., Oda E., Nakajima T., Sekiya S., Oda K. Induction of Sp1 in differentiating human embryonal carcinoma cells triggers transcription of the fibronectin gene. Mol. Cell. Biol. 18:1998;3010-3020.
36. de Nigris F., Franconi F., Maida I., Palumbo G., Anania V., Napoli C. Modulation by α- and γ-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells. Biochem. Pharmacol. 59:2000;1477-1487.
37. Napoli C., Quehenberger O., de Nigris F., Abete P., Glass C.K., Palinski W. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J. 14:2000;1996-2007.
38. Iglesias-de La Cruz M.C., Ruiz-Torres P., Alcamí J., Díez-Marqués L., Ortega-Velázquez R., Chen S., Rodríguez-Puyol M., Ziyadeh F.N., Rodríguez-Puyol D. Hydrogen peroxide increases extracellular matrix mRNA through TGF-β in human mesangial cells. Kidney Int. 59:2001;87-95.
39. Lee Y.W., Kühn H., Hennig B., Neish A.S., Toborek M. IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J. Mol. Cell. Cardiol. 33:2001;83-94.
40. Isono M., Iglesias-de La Cruz M.C., Chen S., Hong S.W., Ziyadeh F.N. Extracellular signal-regulated kinase mediates stimulation of TGF-β1 and matrix by high glucose in mesangial cells. J. Am. Soc. Nephrol. 11:2000;2222-2230.
41. Inoki K., Haneda M., Ishida T., Mori H., Maeda S., Koya D., Sugimoto T., Kikkawa R. Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-β in mesangial cells. Kidney Int. 58(Suppl. 77):2000;S76-S80.
42. Kritharides L., Jessup W., Gifford J., Dean R.T. A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC. Anal. Biochem. 213:1993;79-89.
43. Carpenter K.L.H., Wilkins G.M., Fussell B., Ballantine J.A., Taylor S.E., Mitchinson M.J., Leake D.S. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochem. J. 304:1994;625-633.